摘要
目的:改进利伐沙班的合成工艺,满足产业化生产的要求。方法:以(S)-N-(2,3-环氧丙基)邻苯二甲酰亚胺和4-(4-氨基苯基)-3-吗啉酮为原料,经过缩合、环合、水解、酰化等反应,最终合成利伐沙班。结果:研究以甲磺酸代替原专利中的盐酸合成利伐沙班中间体4-[4-[(5S)-5-(氨甲基)-2-羰基-3-唑烷基]苯基]-3-吗啡啉酮甲磺酸盐,对于路线中的水解、酰化和最终的精制产品的步骤进行了优化,使产品的收率达到96.86%。结论:优化后的工艺改善了原研路线中存在的问题和不足,从而极大地提高了操作的安全性以及可行性,更加满足产业化生产的要求。
Objective:To improve the synthesis process of rivaroxaban while avoiding the patent protection of rivaroxaban.Methods:(S)-(+)-N-(2,3-Epoxypropyl)phthalimide and 4-(4-aMinophenyl)Morpholin-3-one were used as raw materials for the final synthesis of rivaroxaban through condensation,cyclization,hydrolysis and acylation reactions.Results:In the study,the methanesulfonic acid was used instead of hydrochloric acid to synthesize the rivaroxaban intermediate 4-[4-[(5S)-5(aminomethyl)-2-carbonyl-3-azolidinyl]phenyl]-3-morpholinone methanesulfonate,avoiding patent protection.Also,the steps of hydrolysis,acylation and the final refined product in the route were optimized to achieve a product yield of 96.86%.Conclusion:The optimized process not only avoids the problems of patent protection in the original route,but also improves the problems in the original route,thus greatly improving the safety and feasibility of the operation,and better meeting the requirements of industrial production.
作者
刘玉键
付新悦
周微
白万富
LIU Yujian;FU Xinyue;ZHOU Wei;BAI Wanfu(School of Pharmacy,Baotou Medical College,Baotou 014040,China;Tianshili Holding Group Limited Research Institute Chemical Development Center)
出处
《包头医学院学报》
CAS
2022年第12期76-80,共5页
Journal of Baotou Medical College
基金
内蒙古自治区自然科学基金项目(2021LHMS08013)
内蒙古自治区卫生健康科技计划项目(202202226)
包头医学院博士科研启动基金(BSJJ201814)
包头医学院硕士研究生科研创新资助项目(bycx2021009)
自治区大学生创新创业训练计划项目(S202119127004)。